Risk factors for in-hospital mortality in patients with cancer and COVID-19

Affiliations

¹ Department of Predictive Medicine, School of Basic Medical Sciences, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, Henan University, Kaifeng 475004, China.
² Department of Predictive Medicine, School of Basic Medical Sciences, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, Henan University, Kaifeng 475004, China. Electronic address: xqguo@henu.edu.cn.

Comment

Guosen Zhang et al. Lancet Oncol. 2020 Sep.

. 2020 Sep;21(9):e407.

doi: 10.1016/S1470-2045(20)30390-9.

¹ Department of Predictive Medicine, School of Basic Medical Sciences, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, Henan University, Kaifeng 475004, China.
² Department of Predictive Medicine, School of Basic Medical Sciences, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, Henan University, Kaifeng 475004, China. Electronic address: xqguo@henu.edu.cn.

No abstract available

Comment in

Risk factors for in-hospital mortality in patients with cancer and COVID-19.
Guo K, Sun L, Yuan L, Wasan HS, Ruan S. Guo K, et al. Lancet Oncol. 2020 Sep;21(9):e406. doi: 10.1016/S1470-2045(20)30426-5. Lancet Oncol. 2020. PMID: 32888456 Free PMC article. No abstract available.
Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
Yang K, Sheng Y, Wu B, Wu G. Yang K, et al. Lancet Oncol. 2020 Sep;21(9):e408. doi: 10.1016/S1470-2045(20)30467-8. Lancet Oncol. 2020. PMID: 32888458 Free PMC article. No abstract available.

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Yang K, et al. Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479787 Free PMC article.

1. Yang K, Sheng Y, Huang C. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID–19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:904–913. - PMC - PubMed
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
1. CDC COVID-19 Response Team Severe outcomes among patients with coronavirus disease 2019 (COVID–19)–United States, Feb 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343–346. - PMC - PubMed
1. Kattan MW, Hess KR, Amin MB. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66:370–374. - PMC - PubMed